Epistaxis epidemiology and demographics: Difference between revisions
Amir Bagheri (talk | contribs) |
Amir Bagheri (talk | contribs) |
||
| Line 10: | Line 10: | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
Although epistaxis is the most common emergency in ENT, mortality from epistaxis is rare. <br /> | Although epistaxis is the most common emergency in ENT, mortality from epistaxis is rare. <br /><ref name="pmid25705275">{{cite journal| author=Anghel AG, Soreanu CC, Dumitru M, Anghel I| title=Treatment Options for Severe Epistaxis, the Experience of Coltea ENT Clinic. | journal=Maedica (Buchar) | year= 2014 | volume= 9 | issue= 2 | pages= 179-82 | pmid=25705275 | doi= | pmc=4296762 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25705275 }} </ref> | ||
===Age=== | ===Age=== | ||
Revision as of 17:20, 21 September 2020
|
Epistaxis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Epistaxis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Epistaxis epidemiology and demographics |
|
Risk calculators and risk factors for Epistaxis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.
Epidemiology
About 60 percent of people experienced epistaxis at least once, and about 6 percent of people looking for medical action at least once however, epistaxis is hardly lethal.Rate of epistaxis is more in children and old ages [1]
Prevalence
About 60 percent of American people experienced epistaxis at least once, and about 6 percent of people looking for medical action. [1]
Case-fatality rate/Mortality rate
Although epistaxis is the most common emergency in ENT, mortality from epistaxis is rare.
[2]
Age
Epistaxis is more prevalnet in children and elderly patients.[3]
References
- ↑ 1.0 1.1 Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). "Clinical Practice Guideline: Nosebleed (Epistaxis)". Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
- ↑ Anghel AG, Soreanu CC, Dumitru M, Anghel I (2014). "Treatment Options for Severe Epistaxis, the Experience of Coltea ENT Clinic". Maedica (Buchar). 9 (2): 179–82. PMC 4296762. PMID 25705275.
- ↑ Pallin, Daniel J.; Chng, Yi-Mei; McKay, Mary Patricia; Emond, Jennifer A.; Pelletier, Andrea J.; Camargo, Carlos A. (2005). "Epidemiology of Epistaxis in US Emergency Departments, 1992 to 2001". Annals of Emergency Medicine. 46 (1): 77–81. doi:10.1016/j.annemergmed.2004.12.014. ISSN 0196-0644.